Karyopharm Therapeutics Inc (KPTI)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Karyopharm Therapeutics Inc-Aktie (KPTI)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	1.84% 33.13	33.75	36.01	37.58	38.70
Operating Expenses	6.53% 66.89	71.56	67.27	67.15	69.60
Interest Income/Expense	5.22% 5.884	6.208	6.073	5.784	5.758
Benefits Costs and Expenses	6.68% 70.42	75.45	70.50	70.08	72.77
Costs And Expenses	6.68% 70.42	75.45	70.50	70.08	72.77
Operating Income/Loss	10.71% -33.76	-37.81	-31.26	-29.57	-30.90
Nonoperating Income/Loss	9.41% -3.532	-3.899	-3.234	-2.93	-3.173
Income/Loss From Continuing Operations Before Tax	10.59% -37.29	-41.71	-34.49	-32.50	-34.07
Income Tax Expense/Benefit	45.38% 0.071	0.13	0.012	0.127	0.054
Income/Loss From Continuing Operations After Tax	10.70% -37.36	-41.84	-34.51	-32.63	-34.13
Net Income/Loss	10.70% -37.36	-41.84	-34.51	-32.63	-34.13
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	61,312% 115.45	0.188	114.40	114.21	113.48
Diluted Average Shares	61,312% 115.45	0.188	114.40	114.21	113.48
Basic Earnings Per Share	11.11% -0.32	-0.36	-0.30	-0.29	-0.30
Diluted Earnings Per Share	11.11% -0.32	-0.36	-0.30	-0.29	-0.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

GMAB

$21.80

4.81%

INCY

$73.47

2.14%

SMMT

$22.10

16.13%

UTHR

$367.97

2.52%

ONC

$218.70

4.10%

BNTX

$117.25

4.75%